Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cognos Therapeutics
Inglewood, California, United States
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Cognos Therapeutics is developing the SINNAIS™ implantable smart pump, a platform technology for precise, programmable delivery of therapeutics directly to the brain, targeting CNS cancers and neurodegenerative disorders. The company is preparing for clinical trials, focusing initially on chemotherapy (methotrexate) for leptomeningeal carcinomatosis, with broader applications in Alzheimer's, glioblastoma, and pancreatic cancer[2][3].
- Therapeutic areas
- OncologyNeurology
- Modalities
- DeviceDrug delivery device
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Cognos Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cognos Therapeutics.